Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of Calgary

$17,500.00

Determining the Effects of Angiotensin II on Tonic Blood Flow Control by Astrocytes

FY 2014-15

Summary
Optimal blood flow is essential for the moment-to-moment functioning of the brain. When compromised, cognitive functions decline and cell death can occur. While much research aimed at understanding dementias focuses on the demise of neural function, a new direction is to understand how brain blood flow control becomes dysregulated in dementia onset and progression. Local changes in brain blood flow are achieved when resident brain cells communicate to nearby blood vessels to alter their diameter to speed up or slow down blood flow as needed. Astrocytes, which are support cells in the brain, are important regulators of blood flow. New results from the Gordon Lab show that astrocytes maintain the resting tone of blood vessels. This is a previously unrecognized form of blood flow regulation that they call 'tonic' control. The basic cellular mechanisms of this phenomenon are currently being pursued in healthy tissue in the Gordon Lab, and here I propose to test if this new pathway becomes compromised in a model of hypertension, a critical risk factor for the development of dementia. An important therapeutic target in hypertension research is angiotensin II signaling. I will test the idea that angiotensin II compromises the tonic blood flow control pathway in astrocytes. This is important because if tonic blood flow control is impaired, the energy needs of the brain will not be met when angiotensin II levels are elevated. These changes in blood flow control may be important for the onset or worsening of cognitive impairments in dementia.
Program
Master's Award: Canada Graduate Scholarships
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
331500
Name
Mehina Eslam
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Determining the Effects of Angiotensin II on Tonic Blood Flow Control by Astrocytes
Programtype2
Studentship Programs
Orgnameinp2
University of Calgary
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Angiotensin Ii; Astrocytes; Calcium Imaging; Cognitive Decline; Cyclooxygenase-1 Enzyme; Electrophysiology; Hypertension; Neurovascular Coupling; Two-Photon Laser Scanning Microscopy; Vascular Dementia
Abstract
Optimal blood flow is essential for the moment-to-moment functioning of the brain. When compromised, cognitive functions decline and cell death can occur. While much research aimed at understanding dementias focuses on the demise of neural function, a new direction is to understand how brain blood flow control becomes dysregulated in dementia onset and progression. Local changes in brain blood flow are achieved when resident brain cells communicate to nearby blood vessels to alter their diameter to speed up or slow down blood flow as needed. Astrocytes, which are support cells in the brain, are important regulators of blood flow. New results from the Gordon Lab show that astrocytes maintain the resting tone of blood vessels. This is a previously unrecognized form of blood flow regulation that they call 'tonic' control. The basic cellular mechanisms of this phenomenon are currently being pursued in healthy tissue in the Gordon Lab, and here I propose to test if this new pathway becomes compromised in a model of hypertension, a critical risk factor for the development of dementia. An important therapeutic target in hypertension research is angiotensin II signaling. I will test the idea that angiotensin II compromises the tonic blood flow control pathway in astrocytes. This is important because if tonic blood flow control is impaired, the energy needs of the brain will not be met when angiotensin II levels are elevated. These changes in blood flow control may be important for the onset or worsening of cognitive impairments in dementia.
Competitiondate
201412
Approvedterm2
1 yr 0 mth
Pinamesdelim
Mehina, Eslam
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~